First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

  1. Carrato, A.
  2. Benavides, M.
  3. Massutí, B.
  4. Ferreiro-Monteagudo, R.
  5. García Alfonso, P.
  6. Falcó, E.
  7. Reboredo, M.
  8. Cano, T.
  9. Gallego, J.
  10. Viéitez, J.M.
  11. Layos, L.
  12. Salud, A.
  13. Polo, E.
  14. Dotor, E.
  15. Durán-Ogalla, G.
  16. Rodriguez-Garrote, M.
  17. Calvo, A.
  18. Grande, E.
  19. Aranda, E.
Aldizkaria:
BMC Cancer

ISSN: 1471-2407

Argitalpen urtea: 2019

Alea: 19

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/S12885-019-5753-7 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus